Blake D Hamilton, MD in Salt Lake City, UT - Medicare Urology

Blake D Hamilton, MD is a medicare enrolled "Urology" physician in Salt Lake City, Utah. He went to University Of California, San Francisco School Of Medicine and graduated in 1991 and has 33 years of diverse experience with area of expertise as Urology. He is a member of the group practice University Of Utah Adult Services and his current practice location is 50 N Medical Dr, Salt Lake City, Utah. You can reach out to his office (for appointments etc.) via phone at (801) 587-4888.

Blake D Hamilton is licensed to practice in Utah (license number 187531-1205) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1912097510.

Contact Information

	Blake D Hamilton, MD
	50 N Medical Dr, Salt Lake City, UT 84132-0001
	(801) 587-4888
	Not Available

Physician's Profile

Full Name	Blake D Hamilton
Gender	Male
Speciality	Urology
Experience	33 Years
Location	50 N Medical Dr, Salt Lake City, Utah
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Blake D Hamilton attended and graduated from University Of California, San Francisco School Of Medicine in 1991

NPI Data:

NPI Number: 1912097510
Provider Enumeration Date: 10/13/2006
Last Update Date: 12/21/2021

Medicare PECOS Information:

PECOS PAC ID: 8325082316
Enrollment ID: I20050610000235

Medical Identifiers

Medical identifiers for Blake D Hamilton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912097510	NPI	-	NPPES
340014730	Other	UT	RAILROAD MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	187531-1205 (Utah)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
University Of Utah Hospitals And Clinics	Salt lake city, UT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
University Of Utah Adult Services	0941525273	1459

News Archive

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.

International community must continue its support of Rwanda or risk reversing development progress

Cutting aid to Rwanda because of its alleged role in the ongoing conflict in the Democratic Republic of Congo (DRC), which is outlined in a November 2012 U.N. Security Council-commissioned report, "is the wrong approach," Tony Blair, founder of the Africa Governance Initiative, and Howard Buffett, president of the Howard G. Buffett Foundation, write in a Foreign Policy opinion piece, noting that the report, containing "allegations the government strongly denies, ... has led a number of Western governments and multilaterals to suspend aid to Rwanda, totaling $245 million."

Study finds breast cancer in men is increasing though the disease remains rare

The largest study to date of male breast cancer finds, contrary to previous reports, breast cancer rates in men are increasing though the disease remains rare.

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Blake D Hamilton allows following entities to bill medicare on his behalf.

Entity Name	University Of Utah Adult Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683

News Archive

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

International community must continue its support of Rwanda or risk reversing development progress

Study finds breast cancer in men is increasing though the disease remains rare

The largest study to date of male breast cancer finds, contrary to previous reports, breast cancer rates in men are increasing though the disease remains rare.

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Blake D Hamilton is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Blake D Hamilton, MD Po Box 413035, Salt Lake City, UT 84141-3035 Ph: (801) 213-3900	Blake D Hamilton, MD 50 N Medical Dr, Salt Lake City, UT 84132-0001 Ph: (801) 587-4888

News Archive

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

International community must continue its support of Rwanda or risk reversing development progress

Study finds breast cancer in men is increasing though the disease remains rare

The largest study to date of male breast cancer finds, contrary to previous reports, breast cancer rates in men are increasing though the disease remains rare.

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

Urology Doctors in Salt Lake City, UT

Dr. Stephen James Summers, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, Rm 3b420, Salt Lake City, UT 84132 Phone: 801-213-2700 Fax: 801-585-2891
Benjamin James Mccormick, Urology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-213-2704 Fax: 801-585-2891
Leah Stoehr, APRN Urology Medicare: Medicare Enrolled Practice Location: 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-5555
John Evan Thomas, PA-C Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E Rm 3b420, Salt Lake City, UT 84132 Phone: 801-213-2700 Fax: 801-585-2891
Colton K. Leavitt, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2718
Michael W. Mangelson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 389 S 900 E, Salt Lake City, UT 84102 Phone: 385-282-2000 Fax: 385-282-2001
Julia Faith Piwowarski, PA-C Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, Salt Lake City, UT 84132 Phone: 801-581-7304

Blake D Hamilton, MD - Medicare Urology in Salt Lake City, UT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

International community must continue its support of Rwanda or risk reversing development progress

Study finds breast cancer in men is increasing though the disease remains rare

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

Medicare Reassignments

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

International community must continue its support of Rwanda or risk reversing development progress

Study finds breast cancer in men is increasing though the disease remains rare

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

International community must continue its support of Rwanda or risk reversing development progress

Study finds breast cancer in men is increasing though the disease remains rare

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

Urology Doctors in Salt Lake City, UT